A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

著者: Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony
出版年 Invest New Drugs (2018)

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors

著者: Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig
出版事項 2011

Phase 1 Study of VEGF Trap (Aflibercept) Administered Subcutaneously to Patients with Advanced Solid Tumors

著者: Tew, William P., Gordon, Michael, Murren, John, Dupont, Jakob, Pezzulli, Sandra, Aghajanian, Carol, Sabbatini, Paul, Mendelson, David, Schwartz, Lawrence, Gettinger, Scott, Psyrri, Amanda, Cedarbaum, Jesse M., Spriggs, David R.
出版事項 2009

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

著者: Zang, Xingxing, Sullivan, Peggy S, Soslow, Robert A, Waitz, Rebecca, Reuter, Victor E, Wilton, Andrew, Thaler, Howard T, Arul, Manonmani, Slovin, Susan F, Wei, Joyce, Spriggs, David R, Dupont, Jakob, Allison, James P
出版事項 2010

Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of KOS-862 (Epothilone D) in Patients with Advanced Solid Tumors and Lymphoma

著者: Konner, Jason, Grisham, Rachel N., Park, Jae, O’Connor, Owen A., Cropp, Gillian, Johnson, Robert, Hannah, Alison L., Hensley, Martee L., Sabbatini, Paul, Miranov, Svetlana, Danishefsky, Samuel, Hyman, David, Spriggs, David R., Dupont, Jakob, Aghajanian, Carol
出版事項 2011

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

著者: Lockhart, A. Craig, Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Chevalier, Paul, Sternas, Lars, Buzenet, Giliane, Koehler, Elizabeth, Sosman, Jeffrey A., Schwartz, Lawrence H., Gultekin, David H., Koutcher, Jason A., Donnelly, Edwin F., Andal, Ric, Dancy, Isabelle, Spriggs, David R., Tew, William P.
出版事項 2010

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Res...

著者: Ferrarotto, Renata, Mitani, Yoshitsugu, Diao, Lixia, Guijarro, Irene, Wang, Jing, Zweidler-McKay, Patrick, Bell, Diana, William, William N., Glisson, Bonnie S., Wick, Michael J., Kapoun, Ann M., Patnaik, Amita, Eckhardt, Gail, Munster, Pamela, Faoro, Leonardo, Dupont, Jakob, Lee, J. Jack, Futreal, Andrew, El-Naggar, Adel K., Heymach, John V.
出版年 J Clin Oncol (2017)

A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

著者: Hu, Zishuo Ian, Bendell, Johanna C., Bullock, Andrea, LoConte, Noelle K., Hatoum, Hassan, Ritch, Paul, Hool, Hugo, Leach, Joseph W., Sanchez, James, Sohal, Davendra P. S., Strickler, John, Patel, Ravindranath, Wang‐Gillam, Andrea, Firdaus, Irfan, Yu, Kenneth H., Kapoun, Ann M., Holmgren, Eric, Zhou, Lei, Dupont, Jakob, Picozzi, Vincent, Sahai, Vaibhav, O'Reilly, Eileen M.
出版年 Cancer Med (2019)